COVINGTON CAPITAL MANAGEMENT – Halozyme Therapeutics, Inc. Transaction History
COVINGTON CAPITAL MANAGEMENT portfolio value:
$9.78M
portfolio value
COVINGTON CAPITAL MANAGEMENT quarter portfolio value change:
-10.14%
quarter
Halozyme Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | -1.10M | $39.54 | 247.5K | |
| Q2 2022 | share | Increase | 0.00% | 247.5K shares | 10.89M | $44 | 247.5K |